Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Laganà

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Cells|January 20, 2021
The G Protein-Coupled Receptor Kinases (GRKs) in Chemokine Receptor-Mediated Immune Cell Migration: From Molecular Cues to PhysiopathologyMarta Laganà, Géraldine Schlecht-Louf, Françoise Bachelerie
Current Opinion in Oncology|November 26, 2025
Oligometastatic adrenocortical carcinoma: definition and treatmentMarta Laganà, Alfredo Berruti, Salvatore Grisanti, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 12, 2026
Is the EDP-M regimen able to prolong survival in patients with metastatic adrenocortical carcinoma?Alfredo Berruti, Deborah Cosentini, Marta Laganà, et al.
Endocrine|December 19, 2023
Prediction of fragility fractures in men with prostate cancer under androgen deprivation therapy: the importance of a multidisciplinary approach using a mini-invasive diagnostic toolG Mazziotti, A G Lania, Marta Laganà, et al.
Endocrine|September 24, 2021
Different management of adrenocortical carcinoma in children compared to adults: is it time to share guidelines?Salvatore Grisanti, Deborah Cosentini, Marta Laganà, et al.
European Journal of Cancer (Oxford, England : 1990)|February 16, 2024
Letter re: Impact of EDP-M on survival of patients with metastatic adrenocortical carcinoma: A population-based studyMarta Laganà, Deborah Cosentini, Guido Alberto Massimo Tiberio, et al.
Endocrine-Related Cancer|November 12, 2025
The role of 18F-FDG PET/CT in adrenocortical carcinoma: a systematic reviewDomenico Albano, Salvatore Grisanti, Deborah Cosentini, et al.
Current Treatment Options in Oncology|November 18, 2023
The Evolving Treatment Landscape of Medullary Thyroid CancerMarta Laganà, Valentina Cremaschi, Andrea Alberti, et al.
The Journal of Clinical Endocrinology and Metabolism|March 18, 2022
Letter to the Editor From Cosentini et al: "Cytoreductive Surgery of the Primary Tumor in Metastatic Adrenocortical Carcinoma: Impact on Patients' Survival"Deborah Cosentini, Marta Laganà, Antonella Turla, et al.
Frontiers in Oncology|August 21, 2024
Regorafenib-related erythrocytosis in metastatic extra-gastrointestinal stromal tumor: a case reportElena Fassi, Vito Amoroso, Deborah Cosentini, et al.
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Cells|January 20, 2021
The G Protein-Coupled Receptor Kinases (GRKs) in Chemokine Receptor-Mediated Immune Cell Migration: From Molecular Cues to PhysiopathologyMarta Laganà, Géraldine Schlecht-Louf, Françoise Bachelerie
Current Opinion in Oncology|November 26, 2025
Oligometastatic adrenocortical carcinoma: definition and treatmentMarta Laganà, Alfredo Berruti, Salvatore Grisanti, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 12, 2026
Is the EDP-M regimen able to prolong survival in patients with metastatic adrenocortical carcinoma?Alfredo Berruti, Deborah Cosentini, Marta Laganà, et al.
Endocrine|December 19, 2023
Prediction of fragility fractures in men with prostate cancer under androgen deprivation therapy: the importance of a multidisciplinary approach using a mini-invasive diagnostic toolG Mazziotti, A G Lania, Marta Laganà, et al.
Endocrine|September 24, 2021
Different management of adrenocortical carcinoma in children compared to adults: is it time to share guidelines?Salvatore Grisanti, Deborah Cosentini, Marta Laganà, et al.
European Journal of Cancer (Oxford, England : 1990)|February 16, 2024
Letter re: Impact of EDP-M on survival of patients with metastatic adrenocortical carcinoma: A population-based studyMarta Laganà, Deborah Cosentini, Guido Alberto Massimo Tiberio, et al.
Endocrine-Related Cancer|November 12, 2025
The role of 18F-FDG PET/CT in adrenocortical carcinoma: a systematic reviewDomenico Albano, Salvatore Grisanti, Deborah Cosentini, et al.
Current Treatment Options in Oncology|November 18, 2023
The Evolving Treatment Landscape of Medullary Thyroid CancerMarta Laganà, Valentina Cremaschi, Andrea Alberti, et al.
The Journal of Clinical Endocrinology and Metabolism|March 18, 2022
Letter to the Editor From Cosentini et al: "Cytoreductive Surgery of the Primary Tumor in Metastatic Adrenocortical Carcinoma: Impact on Patients' Survival"Deborah Cosentini, Marta Laganà, Antonella Turla, et al.
Frontiers in Oncology|August 21, 2024
Regorafenib-related erythrocytosis in metastatic extra-gastrointestinal stromal tumor: a case reportElena Fassi, Vito Amoroso, Deborah Cosentini, et al.
Pageof 7